Dr. Ryner Lai is a medical writer who is passionate about the power of medical research and innovation to transform the lives of patients. He received his MBBS in Medicine from Queen Mary University ...

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Lauren Holder, an activist and patient with Huntington disease, as well as producer and host of the podcast series Help 4 HD ...

Juliette Siegfried, MPH is a biomedical writer, editor, and translator who has worked in health communications for over 30 years. After working as a health communications specialist for the National ...

Carriers of the SERPINA1 Pi*MZ genotype with alpha-1 antitrypsin deficiency (AATD) and advanced chronic liver disease (ACLD) are at a significantly increased risk of developing hepatocellular ...

A disintegrin and metalloproteinase domain-6 (ADAM6) and serine protease-1 (PRSS1) proteins may represent diagnostic and prognostic biomarkers in patients with acute lymphoblastic leukemia (ALL), ...

Glial fibrillary acidic protein (GFAP) is a potential biomarker for early, preclinical changes in patients with transthyretin amyloid polyneuropathy (ATTR-PN) and could aid in early detection, ...

First-line (1L) ibrutinib provides comparable overall survival outcomes for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), whether or not they have high-risk ...

Advanced age and increased time between symptom onset appear to correlate with increased severity in patients with myasthenia gravis (MG), according to a recently published study in scientific reports ...

Core needle biopsy (CNB) is highly sensitive for diagnosing chronic lymphocytic leukemia (CLL) and several other subtypes of lymphoma, but diagnostic performance varies significantly by subtype, ...

Gaucher disease (GD) does not affect fertility or prevent pregnancy, according to a new study published in the journal Therapeutic Advances in Rare Disease.However, patients with the disease need ...

Time-limited Bruton tyrosine kinase inhibitor (BTKi) treatment may be a viable strategy for some patients with chronic lymphocytic leukemia (CLL), according to findings from a recent patient-reported ...

Inhibition of the neonatal Fc receptor (FcRn), a central player in immunoglobulin (Ig) G homeostasis and immune regulation, offers a precise therapeutic avenue for IgG-mediated autoimmune and ...